Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension
✍ Scribed by Lionel Fizanne; Nicolas Régenet; Jianhua Wang; Frédéric Oberti; Frédéric Moal; Jerôme Roux; Yves Gallois; Sophie Michalak; Paul Calès
- Book ID
- 107593769
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 195 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1936-0533
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The long-term hemodynamic and renal effects of propranolol were compared with those of propranolol plus isosorbide dinitrate in 44 portal-hypertensive alcoholic cirrhotic patients. Eight control patients, 8 patients receiving propranolol and 14 patients receiving propranolol plus isosorbide dinitrat
Short-term carvedilol administration is more powerful than propranolol in decreasing hepatic venous pressure gradient (HVPG) in cirrhotic patients, but induces arterial hypotension that may prevent its long-term use in portal hypertensive patients. This study compared the HVPG reduction and safety o
Although prostaglandins are thought to be involved in the hyperdynamic circulation of portal hypertension, the role of this substance has not been elucidated. Dose-response curves, the hemodynamic effects of prostacyclin (20 k e g ) and its inhibitor indomethacin and measurements of plasma and urina
vein-stenosed rats without affecting the degree of mes-The hemodynamic effects of long-term administration enteric-systemic shunts. (HEPATOLOGY 1996;23:537-543.) of octreotide in portal hypertension has not been established. In addition, whether long-term octreotide treatment prevents the developmen